De novo identification of expressed cancer somatic mutations from single-cell RNA sequencing data

Genome Med. 2023 Dec 18;15(1):115. doi: 10.1186/s13073-023-01269-1.

Abstract

Identifying expressed somatic mutations from single-cell RNA sequencing data de novo is challenging but highly valuable. We propose RESA - Recurrently Expressed SNV Analysis, a computational framework to identify expressed somatic mutations from scRNA-seq data. RESA achieves an average precision of 0.77 on three in silico spike-in datasets. In extensive benchmarking against existing methods using 19 datasets, RESA consistently outperforms them. Furthermore, we applied RESA to analyze intratumor mutational heterogeneity in a melanoma drug resistance dataset. By enabling high precision detection of expressed somatic mutations, RESA substantially enhances the reliability of mutational analysis in scRNA-seq. RESA is available at https://github.com/ShenLab-Genomics/RESA .

Keywords: High precision; Recurrently Expressed SNV Analysis; Single-cell RNA sequencing data; Somatic mutations.

MeSH terms

  • Cluster Analysis
  • Gene Expression Profiling / methods
  • Humans
  • Melanoma* / genetics
  • Mutation
  • Reproducibility of Results
  • Sequence Analysis, RNA / methods
  • Single-Cell Analysis* / methods
  • Software